Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
9.51
-0.53 (-5.28%)
At close: May 28, 2025, 4:00 PM
9.55
+0.04 (0.42%)
After-hours: May 28, 2025, 4:09 PM EDT
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $347.09 million as of May 28, 2025.
Market Cap
347.09M
Enterprise Value
65.54M
1-Year Change
n/a
Ranking
Category
Stock Price
9.51
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has decreased from $601.40M to $347.09M, a decrease of -42.29%. That is a compound annual growth rate of -43.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2025 | 366.44M | -43.53% |
| Dec 31, 2024 | 648.87M | 7.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 640.72B |
| Johnson & Johnson | 367.98B |
| AbbVie | 323.71B |
| Novo Nordisk | 311.77B |
| UnitedHealth Group | 268.12B |
| Abbott Laboratories | 228.44B |
| Novartis AG | 224.07B |
| AstraZeneca | 218.42B |